rs12053975
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_ModerateBP6_ModerateBP7BA1
The NM_001366028.2(DNAH12):c.9639G>C(p.Leu3213=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.233 in 1,527,738 control chromosomes in the GnomAD database, including 45,039 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.23 ( 4503 hom., cov: 32)
Exomes 𝑓: 0.23 ( 40536 hom. )
Consequence
DNAH12
NM_001366028.2 synonymous
NM_001366028.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.183
Genes affected
DNAH12 (HGNC:2943): (dynein axonemal heavy chain 12) Predicted to enable several functions, including ATP binding activity; dynein intermediate chain binding activity; and dynein light intermediate chain binding activity. Predicted to be involved in microtubule-based movement. Predicted to be located in cilium; cytoplasm; and microtubule. Predicted to be part of dynein complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
?
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
?
Variant 3-57352120-C-G is Benign according to our data. Variant chr3-57352120-C-G is described in ClinVar as [Benign]. Clinvar id is 402631.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
?
Synonymous conserved (PhyloP=-0.183 with no splicing effect.
BA1
?
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.387 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DNAH12 | NM_001366028.2 | c.9639G>C | p.Leu3213= | synonymous_variant | 60/74 | ENST00000495027.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DNAH12 | ENST00000495027.6 | c.9639G>C | p.Leu3213= | synonymous_variant | 60/74 | 5 | NM_001366028.2 | P1 | |
DNAH12 | ENST00000351747.6 | c.7035G>C | p.Leu2345= | synonymous_variant | 45/59 | 5 | |||
DNAH12 | ENST00000466540.2 | c.117G>C | p.Leu39= | synonymous_variant | 2/15 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.225 AC: 34195AN: 151848Hom.: 4501 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
34195
AN:
151848
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.278 AC: 38176AN: 137390Hom.: 5786 AF XY: 0.282 AC XY: 20507AN XY: 72688
GnomAD3 exomes
AF:
AC:
38176
AN:
137390
Hom.:
AF XY:
AC XY:
20507
AN XY:
72688
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.233 AC: 321213AN: 1375770Hom.: 40536 Cov.: 32 AF XY: 0.238 AC XY: 161343AN XY: 677544
GnomAD4 exome
AF:
AC:
321213
AN:
1375770
Hom.:
Cov.:
32
AF XY:
AC XY:
161343
AN XY:
677544
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.225 AC: 34207AN: 151968Hom.: 4503 Cov.: 32 AF XY: 0.235 AC XY: 17485AN XY: 74260
GnomAD4 genome
?
AF:
AC:
34207
AN:
151968
Hom.:
Cov.:
32
AF XY:
AC XY:
17485
AN XY:
74260
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1476
AN:
3462
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at